Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimization

	Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimization
	Xu, Hongjiang; Xie, Hui; Zeng, Lili; Zeng, Shaogao; Lu, Xin; Zhao, Xin; Zhang, Guicheng; Tu, Zhengchao; Yang, Ling; Zhang, Xiquan
刊名	EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
	2013
卷号	68
ISSN号	0223-5234
学科主题	Pharmacology & Pharmacy
语种	英语
内容类型	期刊论文
源URL	[http://ir.foo.ac.cn/handle/2SETSVCV/820]
专题	中国科学院广州生物医药与健康研究院
推荐引用方式 GB/T 7714	Xu, Hongjiang,Xie, Hui,Zeng, Lili,et al. Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimization[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2013,68.
APA	Xu, Hongjiang.,Xie, Hui.,Zeng, Lili.,Zeng, Shaogao.,Lu, Xin.,...&Hu, Wenhui.(2013).Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimization.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,68.
MLA	Xu, Hongjiang,et al."Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimization".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 68(2013).